US Patent 11118213 Optimization of multigene analysis of tumor samples
Patent 11118213 was granted and assigned to Foundation Medicine on September, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 15, 2018
Date of Patent
September 14, 2021
Patent Applicant
Patent Application Number
20180215
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11118213 Optimization of multigene analysis of tumor samples
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.